Laura Fabbri, MD, discusses bridging idiopathic pulmonary fibrosis (IPF) and oncology research and putting patients at the center of trial design.
Laura Fabbri, MD
Advertisement
Fabbri, MD, from Imperial College London.
Articles by Laura Fabbri, MD
Laura Fabbri, MD, says patient wishes should guide care decisions in IPF and lung cancer overlap.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Dual Agonist Survodutide Delivers Up to 13.1% Weight Loss in T2D
2
CMS Finalizes Mandatory GLOBE Model to Test Lower Part B Drug Costs
3
FDA Accepts Inhaled Treprostinil sNDA for IPF: 4 FAQs for Payers
4
Proposed Medicare Rate Cuts Draw AASM Opposition Ahead of Final Rule
5